Valuation : IXICO plc

Market Cap 16.35M 22.1M 19.02M 17.9M 30.58M 2.09B 30.67M 212M 81.72M 1.07B 82.93M 81.16M 3.45B P/E 2026 *
-5.36x
P/E 2027 * -5.77x
Enterprise Value 6.15M 8.32M 7.16M 6.74M 11.51M 786M 11.54M 79.59M 30.75M 403M 31.2M 30.54M 1.3B EV / Sales 2026 *
0.77x
EV / Sales 2027 * 1.14x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
1 week-3.23%
Current month-3.23%
1 month-6.25%
3 months-13.29%
6 months-3.85%
Current year-36.17%
1 week 7
Extreme 7
8
1 month 7
Extreme 7
8.5
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 2019-08-20
Director/Board Member 60 2022-01-20
Date Insider Type Main position Quantity % Market Cap. Importance
7/15/26 Buy

Chairman

50,006 0.0228%
6/13/25 Free 350,000 0.3777%
6/13/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.23%-36.71%-63.05% 22.11M
-2.54%-2.84%-1.77%+14.72% 48.93B
-0.40%+1.03%+418.57%+523.39% 45.01B
-1.42%+2.30%+42.67%+21.22% 44.07B
-1.22%-2.31%+4.82%+74.90% 40.73B
+0.53%-1.36%+16.87%+47.12% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+21.42%+123.04% 16.5B
-1.01%+0.50%+13.91%+31.45% 14.67B
-1.65%-1.03%+75.93%+41.22% 13.77B
Average -0.83%+0.16%+61.74%+90.45% 27.5B
Weighted average by Cap. -1.03%+0.11%+89.41%+127.91%

Financials

2026 *2027 *
Net sales 8M 10.81M 9.31M 8.76M 14.96M 1.02B 15.01M 103M 39.98M 524M 40.57M 39.7M 1.69B 9M 12.16M 10.47M 9.85M 16.83M 1.15B 16.88M 116M 44.97M 589M 45.64M 44.67M 1.9B
Net income -2.14M -2.9M -2.49M -2.35M -4.01M -274M -4.02M -27.72M -10.71M -140M -10.87M -10.64M -452M -2.8M -3.79M -3.26M -3.07M -5.24M -358M -5.25M -36.23M -14M -183M -14.2M -13.9M -591M
Net Debt -10.2M -13.79M -11.87M -11.17M -19.07M -1.3B -19.13M -132M -50.97M -668M -51.72M -50.62M -2.15B -6.1M -8.24M -7.1M -6.68M -11.41M -779M -11.44M -78.89M -30.48M -399M -30.93M -30.27M -1.29B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-09-04 GBX 7.500 0.00% 12,823
26-09-03 GBX 7.500 0.00% 57,826
26-09-02 GBX 7.500 0.00% 20,000
26-09-01 GBX 7.500 -3.23% 70,164
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750GBP
Average target price
0.2600GBP
Spread / Average Target
+246.67%

Annual profits - Rate of surprise